This inventor holds 1 USPTO granted patent. Top assignee: Vanderbilt University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Eitan Friedman: Innovator in Cardiovascular Risk Assessment
Introduction
Eitan Friedman is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of cardiovascular health through his innovative research and patent.
Latest Patents
Eitan Friedman holds a patent for a method aimed at identifying subjects with an increased risk of ST-segment elevation myocardial infarction (STEMI). This method involves obtaining a platelet-containing plasma sample from the subject, determining a Prostaglandin E2 (PGE2) phenotype of the platelets, and identifying the subject's risk based on their phenotype. This innovative approach has the potential to enhance early detection and treatment strategies for individuals at risk of STEMI.
Career Highlights
Eitan Friedman is affiliated with Vanderbilt University, where he continues to advance research in cardiovascular health. His work is instrumental in developing methods that could lead to better patient outcomes in the field of cardiology.
Collaborations
Eitan has collaborated with esteemed colleagues, including Elias V Haddad and Olivier Boutaud, to further his research initiatives and enhance the impact of his work.
Conclusion
Eitan Friedman is a pioneering inventor whose contributions to cardiovascular risk assessment are noteworthy. His innovative methods have the potential to significantly improve patient care and outcomes in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile